zyrtec - d 5 mg/120 mg prolonged - release tablets
ucb pharma gmbh - Цетиризин - 5 mg/120 mg prolonged - release tablets
allertesin 10 mg film - coated tablets
warsaw pharmaceutical works polfa sa - Цетиризин - 10 mg film - coated tablets
zodac 10 mg film - coated tablets
zentiva k.s. - Цетиризин - 10 mg film - coated tablets
zodac 5 mg/5 ml syrup
zentiva k.s. - Цетиризина дихидрохлорид - 5 mg/5 ml syrup
zanlan 10 mg film - coated tablets
hexal ag - Цетиризин - 10 mg film - coated tablets
xyzal 5 mg film - coated tablets
ucb pharma gmbh - Левоцетиризин - 5 mg film - coated tablets
xyzal 5 mg/ml oral drops, solution
ucb pharma gmbh - Левоцетиризин - 5 mg/ml oral drops, solution
zenaro 5 mg film - coated tablets
zentiva k.s. - Левоцетиризин - 5 mg film - coated tablets
zipantola 5 mg film - coated tablets
Тева Фармасютикълс България ЕООД - Левоцетиризин - 5 mg film - coated tablets
vanflyta
daiichi sankyo europe gmbh - quizartinib dihydrochloride - Левкемия, миелоид - antineoplastic agents, protein kinase inhibitors - vanflyta is indicated in combination with standard cytarabine and anthracycline induction and standard cytarabine consolidation chemotherapy, followed by vanflyta single-agent maintenance therapy for adult patients with newly diagnosed acute myeloid leukaemia (aml) that is flt3-itd positive.